Clinical trial

Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)

NCT01312337

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2010-09-01

PhasePHASE2

Study timeline

Study start (unknown)2010-09-01Date precision: month

Registry last updated2011-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Nonsmall Cell Lung Cancerunresolved

Interventions

salvage iressaDRUG

Sponsors & collaborators

Samsung Medical Centerlead sponsor

Mapped research locations

SeoulSouth Korea2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01312337 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.